• Je něco špatně v tomto záznamu ?

Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood

T. Svobodova, E. Mejstrikova, U. Salzer, M. Sukova, P. Hubacek, R. Matej, M. Vasakova, L. Hornofova, M. Dvorakova, E. Fronkova, F. Votava, T. Freiberger, P. Pohunek, J. Stary, A. Janda,

. 2015 ; 15 (-) : 8. [pub] 20150210

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028455

Grantová podpora
NT14534 MZ0 CEP - Centrální evidence projektů

BACKGROUND: GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly variable phenotypic features: chronic leukocytopenias (dendritic cell-, monocyto-, granulocyto-, lymphocytopenia), increased susceptibility to infections, lymphatic vasculature abnormalities, and sensorineural deafness. Patients often suffer from opportunistic respiratory infections; chronic pulmonary changes have been found in advanced disease. CASE PRESENTATION: We present a case of a 17-year-old previously healthy Caucasian male who was admitted to the hospital with fever, malaise, headache, cough and dyspnea. A chest X-ray revealed bilateral interstitial infiltrates and pneumonia was diagnosed. Despite prompt clinical improvement under antibiotic therapy, interstitial changes remained stable. A high resolution computer tomography showed severe diffuse parenchymal lung disease, while the patient's pulmonary function tests were normal and he was asymptomatic. Lung tissue biopsy revealed chronic reparative and resorptive reaction with organizing vasculitis. At the time of the initial presentation to the hospital, serological signs of acute infection with Epstein-Barr virus (EBV) were present; EBV viremia with atypical serological response persisted during two-year follow up. No other infectious agents were found. Marked monocytopenia combined with B-cell lymphopenia led to a suspicion of GATA-2 deficiency. Diagnosis was confirmed by detection of the previously published heterozygous mutation in GATA2 (c.1081 C > T, p.R361C). The patient's brother and father were both carriers of the same genetic defect. The brother had no clinically relevant ailments despite leukocyte changes similar to the index patient. The father suffered from spondylarthritis, and apart from B-cell lymphopenia, no other changes within the leukocyte pool were seen. CONCLUSION: We conclude that a diagnosis of GATA-2 deficiency should be considered in all patients with diffuse parenchymal lung disease presenting together with leukocytopenia, namely monocyto-, dendritic cell- and B-lymphopenia, irrespective of severity of the clinical phenotype. Genetic counseling and screening for GATA2 mutations within the patient's family should be provided as the phenotype is highly variable and carriers without apparent immunodeficiency are still in danger of developing myeloid malignancy. A prompt recognition of this rare condition helps to direct clinical treatment strategies and follow-up procedures.

Center for Chronic Immunodeficiency University Medical Center and University of Freiburg Freiburg im Breisgau Germany

Center for Chronic Immunodeficiency University Medical Center and University of Freiburg Freiburg im Breisgau Germany Department of Pediatric Infectious Diseases and Rheumatology Center of Pediatrics and Adolescent Medicine University Medical Center and University of Freiburg Mathildenstrasse 1 79106 Freiburg im Breisgau Germany

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pathology and Molecular Medicine Thomayer's University Hospital Prague Czech Republic

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic Department of Medical Microbiology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pediatrics 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pediatrics 3rd Faculty of Medicine Charles University Prague and University Hospital Kralovske Vinohrady Prague Czech Republic

Department of Radiology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Respiratory Medicine Thomayer's University Hospital Prague Czech Republic

Molecular Genetics Lab Centre for Cardiovascular Surgery and Transplantation Brno Czech Republic Department of Clinical Immunology and Allergology Medical Faculty Masaryk University Brno Brno Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028455
003      
CZ-PrNML
005      
20190828111016.0
007      
ta
008      
161005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12890-015-0006-2 $2 doi
024    7_
$a 10.1186/s12890-015-0006-2 $2 doi
035    __
$a (PubMed)25879889
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Svobodová, Tamara, $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. tamara.svobodova@lfmotol.cuni.cz. $d 1955- $7 mzk2007401084
245    10
$a Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood / $c T. Svobodova, E. Mejstrikova, U. Salzer, M. Sukova, P. Hubacek, R. Matej, M. Vasakova, L. Hornofova, M. Dvorakova, E. Fronkova, F. Votava, T. Freiberger, P. Pohunek, J. Stary, A. Janda,
520    9_
$a BACKGROUND: GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly variable phenotypic features: chronic leukocytopenias (dendritic cell-, monocyto-, granulocyto-, lymphocytopenia), increased susceptibility to infections, lymphatic vasculature abnormalities, and sensorineural deafness. Patients often suffer from opportunistic respiratory infections; chronic pulmonary changes have been found in advanced disease. CASE PRESENTATION: We present a case of a 17-year-old previously healthy Caucasian male who was admitted to the hospital with fever, malaise, headache, cough and dyspnea. A chest X-ray revealed bilateral interstitial infiltrates and pneumonia was diagnosed. Despite prompt clinical improvement under antibiotic therapy, interstitial changes remained stable. A high resolution computer tomography showed severe diffuse parenchymal lung disease, while the patient's pulmonary function tests were normal and he was asymptomatic. Lung tissue biopsy revealed chronic reparative and resorptive reaction with organizing vasculitis. At the time of the initial presentation to the hospital, serological signs of acute infection with Epstein-Barr virus (EBV) were present; EBV viremia with atypical serological response persisted during two-year follow up. No other infectious agents were found. Marked monocytopenia combined with B-cell lymphopenia led to a suspicion of GATA-2 deficiency. Diagnosis was confirmed by detection of the previously published heterozygous mutation in GATA2 (c.1081 C > T, p.R361C). The patient's brother and father were both carriers of the same genetic defect. The brother had no clinically relevant ailments despite leukocyte changes similar to the index patient. The father suffered from spondylarthritis, and apart from B-cell lymphopenia, no other changes within the leukocyte pool were seen. CONCLUSION: We conclude that a diagnosis of GATA-2 deficiency should be considered in all patients with diffuse parenchymal lung disease presenting together with leukocytopenia, namely monocyto-, dendritic cell- and B-lymphopenia, irrespective of severity of the clinical phenotype. Genetic counseling and screening for GATA2 mutations within the patient's family should be provided as the phenotype is highly variable and carriers without apparent immunodeficiency are still in danger of developing myeloid malignancy. A prompt recognition of this rare condition helps to direct clinical treatment strategies and follow-up procedures.
650    _2
$a mladiství $7 D000293
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a infekce virem Epsteina-Barrové $x genetika $x imunologie $7 D020031
650    _2
$a transkripční faktor GATA2 $x nedostatek $x genetika $x imunologie $7 D050989
650    _2
$a lidé $7 D006801
650    _2
$a leukopenie $x genetika $x imunologie $7 D007970
650    _2
$a plíce $x patologie $x radiografie $7 D008168
650    _2
$a intersticiální plicní nemoci $x diagnóza $x genetika $x imunologie $7 D017563
650    _2
$a lymfopenie $x genetika $x imunologie $7 D008231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a monocyty $x imunologie $7 D009000
650    _2
$a mutace $7 D009154
650    _2
$a syndrom $7 D013577
650    _2
$a vaskulitida $x diagnóza $x genetika $x imunologie $7 D014657
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mejstříková, Ester, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. ester.mejstrikova@lfmotol.cuni.cz. $d 1977- $7 xx0105223
700    1_
$a Salzer, Ulrich $u Center for Chronic Immunodeficiency (CCI), University Medical Center and University of Freiburg, Freiburg im Breisgau, Germany. ulrich.salzer@uniklinik-freiburg.de.
700    1_
$a Suková, Martina $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. martina.sukova@fnmotol.cz. $7 xx0128868
700    1_
$a Hubáček, Petr, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.hubacek@lfmotol.cuni.cz. Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.hubacek@lfmotol.cuni.cz. $d 1978- $7 xx0075829
700    1_
$a Matěj, Radoslav, $u Department of Pathology and Molecular Medicine, Thomayer's University Hospital, Prague, Czech Republic. radoslav.matej@ftn.cz. $d 1974- $7 xx0103860
700    1_
$a Koziar Vašáková, Martina, $u Department of Respiratory Medicine, Thomayer's University Hospital, Prague, Czech Republic. martina.vasakova@ftn.cz. $d 1964- $7 xx0104496
700    1_
$a Hornofová, Ludmila $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. hornofova@centrum.cz. $7 xx0248458
700    1_
$a Dvořáková, Marcela $u Department of Radiology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. marcela.dvorakova@fnmotol.cz. $7 xx0237805
700    1_
$a Froňková, Eva, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. eva.fronkova@lfmotol.cuni.cz. $d 1977- $7 xx0105058
700    1_
$a Votava, Felix, $u Department of Pediatrics, 3rd Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic. felix.votava@fnkv.cz. $d 1957- $7 xx0060357
700    1_
$a Freiberger, Tomáš $u Molecular Genetics Lab, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. tomas.freiberger@cktch.cz. Department of Clinical Immunology and Allergology, Medical Faculty, Masaryk University Brno, Brno, Czech Republic. tomas.freiberger@cktch.cz. $7 xx0071641
700    1_
$a Pohunek, Petr, $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.pohunek@lfmotol.cuni.cz. $d 1956- $7 jn99240000886
700    1_
$a Starý, Jan, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. jan.stary@lfmotol.cuni.cz. $d 1952- $7 jn19990009994
700    1_
$a Janda, Ales $u Center for Chronic Immunodeficiency (CCI), University Medical Center and University of Freiburg, Freiburg im Breisgau, Germany. ales.janda@uniklinik-freiburg.de. Department of Pediatric Infectious Diseases and Rheumatology, Center of Pediatrics and Adolescent Medicine, University Medical Center and University of Freiburg, Mathildenstrasse 1, 79106, Freiburg im Breisgau, Germany. ales.janda@uniklinik-freiburg.de.
773    0_
$w MED00008206 $t BMC pulmonary medicine $x 1471-2466 $g Roč. 15, č. - (2015), s. 8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25879889 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20190828111238 $b ABA008
999    __
$a ok $b bmc $g 1166769 $s 953085
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 15 $c - $d 8 $e 20150210 $i 1471-2466 $m BMC pulmonary medicine $n BMC Pulm Med $x MED00008206
GRA    __
$a NT14534 $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...